Keiretsu Forum is pleased to announce today that despite the impact of the global pandemic, its global membership of investors increased its deal activity level by 16% to a record 314 companies receiving funding in 2020. The breakdown of deals funded includes 80% in North America, 15% in Europe and 5% in Asia Pacific region. Life Science, Medical Devices, Environmentally-Sensitive/Aware, and solution-driven Technologies attracted the most capital.
Keiretsu Backs 314 Companies in 2020 - Most Active Early Stage Globally